Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas

Diabetes Care

Volumn 35, Issue 11, 2012, Pages 2148-2155

  Russell, Steven J ^a   El Khatib, Firas H ^b   Nathan, David M ^a   Magyar, Kendra L ^a   Jiang, John ^b   Damiano, Edward R ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROL SYSTEM; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INFUSION SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATIENT SAFETY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON; HUMANS; HYPOGLYCEMIA; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84868109034     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0071     Document Type: Article

References (17)

1. The Diabetes Control and Complications Trial ResearchGroup. The effect of intensive treatment of diabetes on the development and progression of long-termcomplications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
2. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653
3. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287: 2563-2569
4. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes 1997;46:271-286
5. Leese GP, Wang J, Broomhall J, et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003;26:1176-1180
6. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Trans Med 2010;2:27ra27
7. Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984;310:341-346
8. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care 2010;33(Suppl. 1):S11-S61
9. Russell SJ, El-Khatib FH, Nathan DM, Damiano ER. Efficacy determinants of subcutaneous microdose glucagon during closed-loop control. J Diabetes Sci Tech 2010;4:1288-1304
10. Damiano ER, El-Khatib FH, Magyar KL, Nathan DM, Russell SJ. A comparative analysis of three continuous glucose monitors: not all are created equal (Abstract). Diabetes 2012;61(Suppl. 1): A2
11. Kumareswaran K, Elleri D, Allen JM, Harris J, Xing D, Kollman C, et al. Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: The Cambridge Cohort. J Diabetes Sci Technol 2011;5:1352-1362
12. Steil GM, Rebrin K, Darwin C, Hariri F, SaadMF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006;55:3344-3350
13. Weinzimer SA, SteilGM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939
14. Castle JR, Engle JM, El Youssef J, et al. Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 2010;33: 1282-1287
15. Steil GM, Palerm CC, Kurtz N, et al. The effect of insulin feedback on closed loop glucose control. J Clin Endocrinol Metab 2011;96:1402-1408
16. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26:1902-1912
17. Hovorka R, Allen JM, Elleri D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375:743-751